Chemical Compound

Ergostine; Ergotaman-3',6',18-trione, 2'-ethyl-12'-hydroxy-5'-(phenylmethyl)-, (5'a)-; Ergostine (7CI,8CI); (5'a)-2'-Ethyl-12'-hydroxy-5'-(phenylmethyl)ergotaman-3',6',18-trione; (6aR,9R)-N-[(2R,5S,10aS,10bS)-5-Benzyl-2-ethyl-10b-hydroxy-3,6-dioxooctahydro-8H-[1,3]o

CAS Registry Number 2854-38-8
Ergostine; Ergotaman-3',6',18-trione, 2'-ethyl-12'-hydroxy-5'-(phenylmethyl)-, (5'a)-; Ergostine (7CI,8CI); (5'a)-2'-Ethyl-12'-hydroxy-5'-(phenylmethyl)ergotaman-3',6',18-trione; (6aR,9R)-N-[(2R,5S,10aS,10bS)-5-Benzyl-2-ethyl-10b-hydroxy-3,6-dioxooctahydro-8H-[1,3]o 结构式
Primary record

Ergostine; Ergotaman-3',6',18-trione, 2'-ethyl-12'-hydroxy-5'-(phenylmethyl)-, (5'a)-; Ergostine (7CI,8CI); (5'a)-2'-Ethyl-12'-hydroxy-5'-(phenylmethyl)ergotaman-3',6',18-trione; (6aR,9R)-N-[(2R,5S,10aS,10bS)-5-Benzyl-2-ethyl-10b-hydroxy-3,6-dioxooctahydro-8H-[1,3]o

库存
8,913 克
纯度
99.2 %
CAS
2854-38-8

化合物标识与属性

CAS
2854-38-8
PubChem CID
12308959
SMILES
CC[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C
Canonical SMILES
CC[C@@]1(NC(=O)[C@@H]2C=C3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O

名称与同义词

  • Ergostine
  • 8RM45QOC5P
  • UNII-8RM45QOC5P
  • RefChem:137560
  • 2854-38-8
  • SCHEMBL25015102
  • DTXSID10951231
  • C34H37N5O5
  • DTXCID501379360
  • Ergotamine Tartrate EP Impurity C
  • C34-H37-N5-O5
  • Ergotamine EP Impurity C (Free Base)
  • FE30028
  • J2.402.330C
  • ERGOTAMINE TARTRATE IMPURITY C [EP IMPURITY]
  • Q15410939
  • (6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-4-ethyl-2-hydroxy-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
  • Ergotaman-3',6',18-trione, 2'-ethyl-12'-hydroxy-5'-(phenylmethyl)-, (5'alpha)-
  • 2 -Ethyl-12 -hydroxy-5 alpha-benzylergotaman-3 ,6 ,18-trione
  • (4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-4-ethyl-2-hydroxy-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
  • (6aR,9R)-N-((1S,2S,4R,7S)-7-benzyl-4-ethyl-2-hydroxy-5,8-dioxo-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo(4,3-fg)quinoline-9-carboxamide
  • (6aR,9R)-N-((2R,5S,10aS,10bS)-5-benzyl-2-ethyl-10b-hydroxy-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
  • (6AR,9R)-N-((2R,5S,10AS,10BS)-5-BENZYL-2-ETHYL-10B-HYDROXY-3,6-DIOXOOCTAHYDRO-8H-(1,3)OXAZOLO(3,2-A)PYRROLO(2,1-C)PYRAZIN-2-YL)-7-METHYL-4,6,6A,7,8,9-HEXAHYDROINDOLO(4,3-FG)QUINOLINE-9-CARBOXAMIDE
  • Ergostine; Ergotaman-3',6',18-trione, 2'-ethyl-12'-hydroxy-5'-(phenylmethyl)-, (5'a)-; Ergostine (7CI,8CI); (5'a)-2'-Ethyl-12'-hydroxy-5'-(phenylmethyl)ergotaman-3',6',18-trione; (6aR,9R)-N-[(2R,5S,10aS,10bS)-5-Benzyl-2-ethyl-10b-hydroxy-3,6-dioxooctahydro-8H-[1,3]o
  • ERGOTAMAN-3',6',18-TRIONE, 2'-ETHYL-12'-HYDROXY-5'-(PHENYLMETHYL)-, (5'.ALPHA.)-